eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Manuscripts accepted About the journal Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank
6/2017
vol. 13
 
Share:
Share:
more
 
 
abstract:
Basic research

Up-regulation of the long non-coding RNA RMRP contributes to glioma progression and promotes glioma cell proliferation and invasion

Wenxian Feng
,
Li Li
,
Xuchang Xu
,
Yunqi Jiao
,
Wei Du

Arch Med Sci 2017; 13, 6: 1315–1321
Online publish date: 2017/03/23
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction: Gliomas are the most common malignant tumors of the brain. Long non-coding RNAs (lncRNAs) play key regulatory roles in various tumors. In this study, we aimed to determine the expression and biological roles of lncRNA RMRP in glioma.

Material and methods: The relative expression level of lncRNA RMRP was determined by quantitative real-time polymerase chain reaction (qRT-PCR) in a total of 39 patients with glioma. RNA interference (RNAi) approaches were used to investigate the biological functions of RMRP. The effect of lncRNA RMRP on proliferation was determined by CCK8 assay. Cell cycle and apoptosis were evaluated by flow cytometry analysis. Cell migration was explored by the wound-healing assay. Cell invasion was investigated by the Transwell invasion assay.

Results: LncRNA RMRP was up-regulated in human glioma tissues compared with normal brain tissues. LncRNA RMRP up-regulation was significantly correlated with advanced tumor grade and low Karnofsky Performance Score (KPS). Moreover, patients with a high expression level of lncRNA RMRP had a relatively poor prognosis. Multivariate analyses revealed that lncRNA RMRP expression served as an independent predictor for overall survival of glioma patients. In addition, inhibition of lncRNA RMRP by RNAi significantly suppressed the proliferation, migration and invasion of glioma cells in vitro.

Conclusions: lncRNA RMRP might act as an oncogene and could be used as a therapeutic target for the treatment of glioma. Our findings provide an in-depth insight into the role of lncRNA RMRP in glioma progression.
keywords:

long non-coding RNAs, RMRP, glioma, prognosis, progression

FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe